Will $40m per year FCF (on a 50% basis with the rest going to ENAMCO) really interest a major? This is only for the first two phases as I understand it so far (based on the research I have done so far on the project) and doesn't include the other products that can be produced in addition to the SOP. I've not been able to find the estimated FCF projections for the later phases of the project. Does anyone have any links I can browse?
- Forums
- ASX - By Stock
- DNK
- Summary of DNK
Summary of DNK, page-7
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNK (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $151.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DNK (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online